419.4K XNYS Volume
XNYS 19 Mar, 2025 3:20 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 255.63 per share. | 05 Mar 2025 | 500 | 13,166 (0%) | 0% | 255.6 | 127,817 | Common Stock |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.43 per share. | 28 Feb 2025 | 3,903 | 10,299 (0%) | 0% | 131.4 | 512,971 | Common Stock |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 3,903 | 0 | - | - | Non-qualified Stock Options | |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Sale of securities on an exchange or to another person at price $ 249.23 per share. | 28 Feb 2025 | 5,339 | 4,960 (0%) | 0% | 249.2 | 1,330,639 | Common Stock |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 251.30 per share. | 25 Feb 2025 | 1,314 | 2,170 (0%) | 0% | 251.3 | 330,208 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 250.40 per share. | 24 Feb 2025 | 226 | 4,544 (0%) | 0% | 250.4 | 56,590 | Common Stock |
| Glenn A. Eisenberg | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 807 | 2,819 | - | - | Restricted Stock Unit | |
| Glenn A. Eisenberg | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 807 | 33,458 (0%) | 0% | - | Common Stock | |
| Glenn A. Eisenberg | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.14 per share. | 11 Feb 2025 | 213 | 33,245 (0%) | 0% | 245.1 | 52,215 | Common Stock |
| Kerrii B. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
| Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
| Anita Z. Graham | EVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 3,200 | 3,200 | - | - | Non-qualified Stock Options | |
| Anita Z. Graham | EVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 1,070 | 2,091 | - | - | Restricted Stock Unit | |
| Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.14 per share. | 11 Feb 2025 | 1,226 | 88,182 (0%) | 0% | 245.1 | 300,542 | Common Stock |
| Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 2,963 | 89,408 (0%) | 0% | - | Common Stock | |
| Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 33,100 | 33,100 | - | - | Non-qualified Stock Options | |
| Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 10,970 | 26,102 | - | - | Restricted Stock Unit | |
| Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 2,963 | 23,139 | - | - | Restricted Stock Unit | |
| Adam H. Schechter | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 244.62 per share. | 11 Feb 2025 | 6,121 | 86,445 (0%) | 0% | 244.6 | 1,497,319 | Common Stock |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.15 per share. | 11 Feb 2025 | 41 | 2,344 (0%) | 0% | 245.1 | 10,051 | Common Stock |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 1,500 | 1,500 | - | - | Non-qualified Stock Options | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 480 | 1,004 | - | - | Restricted Stock Unit | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 123 | 2,385 (0%) | 0% | - | Common Stock | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 1,610 | 2,614 | - | - | Restricted Stock Unit | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 123 | 2,491 | - | - | Restricted Stock Unit | |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 1,130 | 2,580 | - | - | Restricted Stock Unit | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 323 | 3,570 (0%) | 0% | - | Common Stock | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.14 per share. | 11 Feb 2025 | 86 | 3,484 (0%) | 0% | 245.1 | 21,082 | Common Stock |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 3,400 | 3,400 | - | - | Non-qualified Stock Options | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 323 | 2,257 | - | - | Restricted Stock Unit | |
| Richelle P. Parham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
| Paul B. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
| D. Gary Gilliland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
| Lance V. Berberian | EVP, Special Advisor, Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.14 per share. | 11 Feb 2025 | 86 | 16,680 (0%) | 0% | 245.1 | 21,082 | Common Stock |
| Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 323 | 16,766 (0%) | 0% | - | Common Stock | |
| Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 323 | 1,067 | - | - | Restricted Stock Unit | |
| Jeffrey A. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 6,700 | 6,700 | - | - | Non-qualified Stock Options | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 473 | 4,188 | - | - | Restricted Stock Unit | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 473 | 29,471 (0%) | 0% | - | Common Stock | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 2,220 | 4,661 | - | - | Restricted Stock Unit | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.14 per share. | 11 Feb 2025 | 136 | 29,335 (0%) | 0% | 245.1 | 33,339 | Common Stock |
| Kathryn E. Wengel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 7,300 | 7,300 | - | - | Non-qualified Stock Options | |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 473 | 6,530 (0%) | 0% | - | Common Stock | |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.14 per share. | 11 Feb 2025 | 134 | 6,396 (0%) | 0% | 245.1 | 32,849 | Common Stock |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 2,420 | 5,061 | - | - | Restricted Stock Unit | |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 473 | 4,588 | - | - | Restricted Stock Unit | |
| Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 690 | 1,560 | - | - | Restricted Stock Unit | |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 201 | 4,825 (0%) | 0% | - | Common Stock | |
| Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 2,100 | 2,100 | - | - | Non-qualified Stock Options | |
| Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.15 per share. | 11 Feb 2025 | 55 | 4,770 (0%) | 0% | 245.1 | 13,483 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 201 | 1,359 | - | - | Restricted Stock Unit | |
| Julia Wang A. | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 2,580 | 4,367 | - | - | Restricted Stock Unit | |
| Julia Wang A. | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 7,800 | 7,800 | - | - | Non-qualified Stock Options | |
| Kirsten Marie Kliphouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 1,210 | 7,256 | - | - | Restricted Stock Unit | |
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 3,700 | 3,700 | - | - | Non-qualified Stock Options | |
| Akinbolade Oyegunwa | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 2,100 | 2,100 | - | - | Non-qualified Stock Options | |
| Akinbolade Oyegunwa | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 134 | 3,016 (0%) | 0% | - | Common Stock | |
| Akinbolade Oyegunwa | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 134 | 2,309 | - | - | Restricted Stock Unit | |
| Akinbolade Oyegunwa | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 690 | 2,443 | - | - | Restricted Stock Unit | |
| Akinbolade Oyegunwa | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.14 per share. | 11 Feb 2025 | 42 | 2,974 (0%) | 0% | 245.1 | 10,296 | Common Stock |
| Glenn A. Eisenberg | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 885 | 3,626 | - | - | Restricted Stock Unit | |
| Glenn A. Eisenberg | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 885 | 32,885 (0%) | 0% | - | Common Stock | |
| Glenn A. Eisenberg | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 255 | 32,000 (0%) | 0% | 247.7 | 63,174 | Common Stock |
| Glenn A. Eisenberg | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 966 | 4,511 | - | - | Restricted Stock Unit | |
| Glenn A. Eisenberg | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 234 | 32,651 (0%) | 0% | 246.3 | 57,627 | Common Stock |
| Glenn A. Eisenberg | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 966 | 32,255 (0%) | 0% | - | Common Stock | |
| Kerrii B. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
| Kerrii B. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 13,666 (0%) | 0% | - | Common Stock | |
| Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 12,887 (0%) | 0% | - | Common Stock | |
| Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
| Anita Z. Graham | EVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 118 | 500 (0%) | 0% | 247.7 | 29,233 | Common Stock |
| Anita Z. Graham | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 369 | 1,021 | - | - | Restricted Stock Unit | |
| Anita Z. Graham | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 326 | 1,390 | - | - | Restricted Stock Unit | |
| Anita Z. Graham | EVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 119 | 750 (0%) | 0% | 246.3 | 29,306 | Common Stock |
| Anita Z. Graham | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 369 | 869 (0%) | 0% | - | Common Stock | |
| Anita Z. Graham | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 326 | 618 (0%) | 0% | - | Common Stock | |
| Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 4,460 | 91,901 (0%) | 0% | - | Common Stock | |
| Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 1,240 | 90,661 (0%) | 0% | 247.7 | 307,198 | Common Stock |
| Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 3,250 | 93,911 (0%) | 0% | - | Common Stock | |
| Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 1,345 | 92,566 (0%) | 0% | 246.3 | 331,233 | Common Stock |
| Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 4,460 | 18,382 | - | - | Restricted Stock Unit | |
| Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 3,250 | 15,132 | - | - | Restricted Stock Unit | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 134 | 2,308 (0%) | 0% | - | Common Stock | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 46 | 2,174 (0%) | 0% | 247.7 | 11,396 | Common Stock |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.26 per share. | 06 Feb 2025 | 46 | 2,262 (0%) | 0% | 246.3 | 11,328 | Common Stock |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 133 | 658 | - | - | Restricted Stock Unit | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 134 | 524 | - | - | Restricted Stock Unit | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 133 | 2,220 (0%) | 0% | - | Common Stock | |
| Garheng Kong | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 12,842 (0%) | 0% | - | Common Stock | |
| Garheng Kong | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 386 | 1,804 | - | - | Restricted Stock Unit | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 386 | 3,089 (0%) | 0% | - | Common Stock | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 102 | 2,987 (0%) | 0% | 247.7 | 25,269 | Common Stock |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 354 | 3,341 (0%) | 0% | - | Common Stock | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 94 | 3,247 (0%) | 0% | 246.3 | 23,149 | Common Stock |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 354 | 1,450 | - | - | Restricted Stock Unit | |
| Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
| Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 9,478 (0%) | 0% | - | Common Stock | |
| Paul B. Rothman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 1,674 (0%) | 0% | - | Common Stock | |
| Paul B. Rothman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
| D. Gary Gilliland | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 8,656 (0%) | 0% | - | Common Stock | |
| D. Gary Gilliland | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
| Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 354 | 1,390 | - | - | Restricted Stock Unit | |
| Lance V. Berberian | EVP, Special Advisor, Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 94 | 16,183 (0%) | 0% | 247.7 | 23,288 | Common Stock |
| Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 356 | 16,277 (0%) | 0% | - | Common Stock | |
| Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 356 | 1,744 | - | - | Restricted Stock Unit | |
| Lance V. Berberian | EVP, Special Advisor, Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 94 | 16,443 (0%) | 0% | 246.3 | 23,149 | Common Stock |
| Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 354 | 16,537 (0%) | 0% | - | Common Stock | |
| Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
| Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 4,563 (0%) | 0% | - | Common Stock | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 517 | 2,553 | - | - | Restricted Stock Unit | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 517 | 29,068 (0%) | 0% | - | Common Stock | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 212 | 28,551 (0%) | 0% | 247.7 | 52,521 | Common Stock |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 670 | 28,763 (0%) | 0% | - | Common Stock | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 149 | 28,919 (0%) | 0% | 246.3 | 36,694 | Common Stock |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 112 | 29,031 (0%) | 0% | - | Common Stock | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 33 | 28,998 (0%) | 0% | 246.3 | 8,127 | Common Stock |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 670 | 3,070 | - | - | Restricted Stock Unit | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 112 | 2,441 | - | - | Restricted Stock Unit | |
| Kathryn E. Wengel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
| Kathryn E. Wengel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 3,236 (0%) | 0% | - | Common Stock | |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 743 | 3,322 | - | - | Restricted Stock Unit | |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 743 | 5,779 (0%) | 0% | - | Common Stock | |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 210 | 5,569 (0%) | 0% | 247.7 | 52,025 | Common Stock |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 517 | 6,086 (0%) | 0% | - | Common Stock | |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 146 | 5,940 (0%) | 0% | 246.3 | 35,955 | Common Stock |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 164 | 6,104 (0%) | 0% | - | Common Stock | |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.28 per share. | 06 Feb 2025 | 47 | 6,057 (0%) | 0% | 246.3 | 11,575 | Common Stock |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 517 | 2,805 | - | - | Restricted Stock Unit | |
| Mark S. Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 164 | 2,641 | - | - | Restricted Stock Unit | |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 223 | 1,094 | - | - | Restricted Stock Unit | |
| Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.26 per share. | 06 Feb 2025 | 68 | 4,624 (0%) | 0% | 246.3 | 16,746 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 224 | 4,692 (0%) | 0% | - | Common Stock | |
| Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 73 | 4,468 (0%) | 0% | 247.7 | 18,085 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 223 | 4,541 (0%) | 0% | - | Common Stock | |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 224 | 870 | - | - | Restricted Stock Unit | |
| Julia Wang A. | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 336 | 557 (0%) | 0% | 247.7 | 83,241 | Common Stock |
| Julia Wang A. | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 893 | 893 (0%) | 0% | - | Common Stock | |
| Julia Wang A. | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 893 | 1,787 | - | - | Restricted Stock Unit | |
| Kirsten Marie Kliphouse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
| Kirsten Marie Kliphouse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 2,263 (0%) | 0% | - | Common Stock | |
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 67 | 752 (0%) | 0% | - | Common Stock | |
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 85 | 685 (0%) | 0% | 246.3 | 20,933 | Common Stock |
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 224 | 770 (0%) | 0% | - | Common Stock | |
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 70 | 546 (0%) | 0% | 247.7 | 17,342 | Common Stock |
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 180 | 616 (0%) | 0% | - | Common Stock | |
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 224 | 6,113 | - | - | Restricted Stock Unit | |
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 180 | 6,337 | - | - | Restricted Stock Unit | |
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 67 | 6,046 | - | - | Restricted Stock Unit | |
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 22 | 730 (0%) | 0% | 246.3 | 5,418 | Common Stock |
| Akinbolade Oyegunwa | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 180 | 1,902 | - | - | Restricted Stock Unit | |
| Akinbolade Oyegunwa | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 149 | 1,753 | - | - | Restricted Stock Unit | |
| Akinbolade Oyegunwa | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 51 | 2,882 (0%) | 0% | 246.3 | 12,560 | Common Stock |
| Akinbolade Oyegunwa | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 149 | 2,933 (0%) | 0% | - | Common Stock | |
| Akinbolade Oyegunwa | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 62 | 2,784 (0%) | 0% | 247.7 | 15,360 | Common Stock |
| Akinbolade Oyegunwa | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 180 | 2,846 (0%) | 0% | - | Common Stock | |
| Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 07 Jan 2025 | 1,000 | 12,722 (0%) | 0% | 235 | 235,000 | Common Stock |
| Gilliland D. Gary | Director | Sale of securities on an exchange or to another person at price $ 241.00 per share. | 02 Dec 2024 | 1,000 | 7,712 (0%) | 0% | 241 | 241,000 | Common Stock |
| Glenn Eisenberg A. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 209.25 per share. | 02 Dec 2024 | 8,923 | 40,212 (0%) | 0% | 209.3 | 1,867,138 | Common Stock |
| Wang Julia | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 2,680 | 2,680 | - | - | Restricted Stock Unit | |
| Glenn Eisenberg A. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 8,923 | 0 | - | - | Non-qualified Stock Options | |
| A. Eisenberg Glenn | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 221.67 per share. | 02 Dec 2024 | 2,788 | 43,000 (0%) | 0% | 221.7 | 618,016 | Common Stock |
| Julia Wang | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 8,100 | 8,100 | - | - | Non-qualified Stock Options | |
| Eisenberg Glenn A. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 2,788 | 5,577 | - | - | Non-qualified Stock Options | |
| Glenn A. Eisenberg | Executive Vice President | Sale of securities on an exchange or to another person at price $ 240.43 per share. | 02 Dec 2024 | 11,711 | 31,289 (0%) | 0% | 240.4 | 2,815,651 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 4,015 | 0 | - | - | Non-qualified Stock Options | |
| Amy B. Summy | EVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 238.94 per share. | 22 Nov 2024 | 3,671 | 4,318 (0%) | 0% | 238.9 | 877,142 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 168.52 per share. | 22 Nov 2024 | 4,015 | 7,990 (0%) | 0% | 168.5 | 676,608 | Common Stock |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 239.42 per share. | 21 Nov 2024 | 1,000 | 2,669 (0%) | 0% | 239.4 | 239,419 | Common Stock |
| Adam H. Schechter | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 243.47 per share. | 11 Nov 2024 | 6,189 | 87,441 (0%) | 0% | 243.5 | 1,506,836 | Common Stock |
| Megan D. Bailey | EVP, Pres, Central Labs & Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 1,110 | 6,517 | - | - | Restricted Stock Unit | |
| Akinbolade Oyegunwa | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 1,110 | 2,082 | - | - | Restricted Stock Unit | |
| Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 230.00 per share. | 24 Oct 2024 | 1,000 | 13,722 (0%) | 0% | 230 | 230,000 | Common Stock |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 227.05 per share. | 19 Aug 2024 | 2,000 | 3,669 (0%) | 0% | 227.1 | 454,100 | Common Stock |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 224.55 per share. | 15 Aug 2024 | 9,071 | 31,289 (0%) | 0% | 224.5 | 2,036,882 | Common Stock |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 222.65 per share. | 15 Aug 2024 | 2,979 | 43,310 (0%) | 0% | 222.6 | 663,273 | Common Stock |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 223.62 per share. | 15 Aug 2024 | 2,950 | 40,360 (0%) | 0% | 223.6 | 659,670 | Common Stock |
| Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 225.00 per share. | 07 Aug 2024 | 586 | 14,722 (0%) | 0% | 225 | 131,850 | Common Stock |
| Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 225.00 per share. | 07 Aug 2024 | 414 | 15,308 (0%) | 0% | 225 | 93,150 | Common Stock |
| Lance V. Berberian | EVP, CIO & CTO | Sale of securities on an exchange or to another person at price $ 229.78 per share. | 05 Aug 2024 | 2,245 | 25,769 (0%) | 0% | 229.8 | 515,867 | Common Stock |
| Lance V. Berberian | EVP, CIO & CTO | Sale of securities on an exchange or to another person at price $ 228.95 per share. | 05 Aug 2024 | 9,848 | 15,921 (0%) | 0% | 228.9 | 2,254,685 | Common Stock |
| Paul B. Rothman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 717 | 944 | - | - | Restricted Stock Unit | |
| Paul B. Rothman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 717 | 717 (0%) | 0% | - | Common Stock | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 210.83 per share. | 14 May 2024 | 1,800 | 5,836 (0%) | 0% | 210.8 | 379,488 | Common Stock |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 210.84 per share. | 14 May 2024 | 200 | 5,636 (0%) | 0% | 210.8 | 42,167 | Common Stock |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.37 per share. | 30 Apr 2024 | 4,496 | 46,289 (0%) | 0% | 201.4 | 905,360 | Common Stock |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 10,229 | 50,785 (0%) | 0% | - | Common Stock | |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 10,229 | 0 | - | - | Performance Share Unit | |
| Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 200.10 per share. | 30 Apr 2024 | 250 | 15,722 (0%) | 0% | 200.1 | 50,025 | Common Stock |
| Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 204.14 per share. | 30 Apr 2024 | 250 | 15,972 (0%) | 0% | 204.1 | 51,034 | Common Stock |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 204.33 per share. | 29 Apr 2024 | 2,439 | 2,087 (0%) | 0% | 204.3 | 498,358 | Common Stock |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 10,229 | 5,477 | - | - | Restricted Stock Unit | |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 203.32 per share. | 15 Apr 2024 | 4,496 | 40,556 (0%) | 0% | 203.3 | 914,127 | Common Stock |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 10,229 | 45,052 (0%) | 0% | - | Common Stock | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Sale of securities on an exchange or to another person at price $ 217.29 per share. | 01 Apr 2024 | 6,477 | 5,036 (0%) | 0% | 217.3 | 1,407,387 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 217.29 per share. | 01 Apr 2024 | 3,500 | 3,975 (0%) | 0% | 217.3 | 760,515 | Common Stock |
| Megan D. Bailey | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 205 | 505 (0%) | 0% | - | Common Stock | |
| Megan D. Bailey | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 205 | 5,407 | - | - | Restricted Stock Unit | |
| Megan D. Bailey | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 216.35 per share. | 01 Apr 2024 | 69 | 436 (0%) | 0% | 216.3 | 14,928 | Common Stock |
| Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 216.57 per share. | 27 Mar 2024 | 3,299 | 28,014 (0%) | 0% | 216.6 | 714,464 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 216.57 per share. | 27 Mar 2024 | 2,162 | 7,475 (0%) | 0% | 216.6 | 468,224 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 5,778 | 1,317 | - | - | Restricted Stock Unit | |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 5,778 | 9,637 (0%) | 0% | - | Common Stock | |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 20,033 | 15,706 | - | - | Restricted Stock Unit | |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 20,033 | 43,628 (0%) | 0% | - | Common Stock | |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 216.57 per share. | 27 Mar 2024 | 8,805 | 34,823 (0%) | 0% | 216.6 | 1,906,899 | Common Stock |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 216.57 per share. | 27 Mar 2024 | 894 | 4,526 (0%) | 0% | 216.6 | 193,614 | Common Stock |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 3,079 | 791 | - | - | Restricted Stock Unit | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 3,079 | 5,420 (0%) | 0% | - | Common Stock | |
| Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 7,697 | 2,100 | - | - | Restricted Stock Unit | |
| Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 7,697 | 31,313 (0%) | 0% | - | Common Stock | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 2,119 | 0 | - | - | Non-qualified Stock Options | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.09 per share. | 07 Mar 2024 | 2,119 | 10,084 (0%) | 0% | 117.1 | 248,114 | Common Stock |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Sale of securities on an exchange or to another person at price $ 218.45 per share. | 07 Mar 2024 | 5,048 | 5,036 (0%) | 0% | 218.5 | 1,102,736 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 218.45 per share. | 07 Mar 2024 | 227 | 3,859 (0%) | 0% | 218.4 | 49,588 | Common Stock |
| A. Eisenberg Glenn | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 215.68 per share. | 21 Feb 2024 | 7,907 | 31,813 (0%) | 0% | 215.7 | 1,705,349 | Common Stock |
| A. Glenn Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 14,054 | 0 | - | - | Non-qualified Stock Options | |
| Eisenberg A. Glenn | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 163.63 per share. | 21 Feb 2024 | 14,054 | 58,099 (0%) | 0% | 163.6 | 2,299,656 | Common Stock |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 217.98 per share. | 21 Feb 2024 | 1,553 | 23,595 (0%) | 0% | 218.0 | 338,529 | Common Stock |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 215.37 per share. | 21 Feb 2024 | 18,379 | 39,720 (0%) | 0% | 215.4 | 3,958,214 | Common Stock |
| Glenn Eisenberg A. | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 217.52 per share. | 21 Feb 2024 | 6,665 | 25,148 (0%) | 0% | 217.5 | 1,449,774 | Common Stock |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Sale of securities on an exchange or to another person at price $ 215.49 per share. | 21 Feb 2024 | 500 | 3,400 (0%) | 0% | 215.5 | 107,745 | Common Stock |
| van der Vaart Sandra D. | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 226.45 per share. | 13 Feb 2024 | 237 | 7,636 (0%) | 0% | 226.5 | 53,669 | Common Stock |
| A. Glenn Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 807 | 44,260 (0%) | 0% | - | Common Stock | |
| B. Amy Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.45 per share. | 11 Feb 2024 | 66 | 4,086 (0%) | 0% | 227.5 | 15,012 | Common Stock |
| Amy Summy B. | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 201 | 7,095 | - | - | Restricted Stock Unit | |
| Schechter H. Adam | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 2,964 | 95,277 | - | - | Restricted Stock Unit | |
| Wilkinson J. Peter | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.44 per share. | 11 Feb 2024 | 43 | 2,341 (0%) | 0% | 227.4 | 9,780 | Common Stock |
| H. Schechter Adam | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.45 per share. | 11 Feb 2024 | 1,231 | 52,994 (0%) | 0% | 227.5 | 279,991 | Common Stock |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.45 per share. | 11 Feb 2024 | 215 | 44,045 (0%) | 0% | 227.5 | 48,902 | Common Stock |
| Sandra van der Vaart D. | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 324 | 8,348 | - | - | Restricted Stock Unit | |
| J. Brian Caveney | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.45 per share. | 11 Feb 2024 | 137 | 21,386 (0%) | 0% | 227.5 | 31,161 | Common Stock |
| Berberian V. Lance | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 324 | 23,703 (0%) | 0% | - | Common Stock | |
| Sandra van der Vaart D. | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 324 | 7,960 (0%) | 0% | - | Common Stock | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 123 | 2,384 (0%) | 0% | - | Common Stock | |
| Summy Amy B. | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 201 | 4,152 (0%) | 0% | - | Common Stock | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.45 per share. | 11 Feb 2024 | 87 | 7,873 (0%) | 0% | 227.4 | 19,788 | Common Stock |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 472 | 8,091 (0%) | 0% | - | Common Stock | |
| Eisenberg Glenn A. | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 807 | 35,739 | - | - | Restricted Stock Unit | |
| Brian Caveney J. | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 472 | 21,523 (0%) | 0% | - | Common Stock | |
| J. Caveney Brian | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 472 | 15,296 | - | - | Restricted Stock Unit | |
| J. Peter Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 123 | 3,870 | - | - | Restricted Stock Unit | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.45 per share. | 11 Feb 2024 | 126 | 7,965 (0%) | 0% | 227.5 | 28,659 | Common Stock |
| Berberian Lance V. | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.45 per share. | 11 Feb 2024 | 87 | 23,616 (0%) | 0% | 227.4 | 19,788 | Common Stock |
| Adam Schechter H. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 2,964 | 54,225 (0%) | 0% | - | Common Stock | |
| Lance Berberian V. | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 324 | 9,797 | - | - | Restricted Stock Unit | |
| Schroeder Mark | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 472 | 15,621 | - | - | Restricted Stock Unit | |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 201 | 3,959 (0%) | 0% | - | Common Stock | |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.46 per share. | 11 Feb 2024 | 59 | 3,900 (0%) | 0% | 227.5 | 13,420 | Common Stock |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 201 | 4,977 | - | - | Restricted Stock Unit | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 222.06 per share. | 08 Feb 2024 | 259 | 7,636 (0%) | 0% | 222.1 | 57,514 | Common Stock |
| Kirsten Marie Kliphouse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 944 | - | - | Restricted Stock Unit | |
| Caveney Brian J. | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 2,010 | 16,397 | - | - | Restricted Stock Unit | |
| Kliphouse Marie Kirsten | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 1,319 (0%) | 0% | - | Common Stock | |
| Paul Rothman B. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 944 | 1,661 | - | - | Restricted Stock Unit | |
| A. Davis Jeffrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 944 | 1,891 | - | - | Restricted Stock Unit | |
| Eisenberg Glenn A. | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 885 | 43,689 (0%) | 0% | - | Common Stock | |
| Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 353 | 23,473 (0%) | 0% | - | Common Stock | |
| D. Bailey Megan | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.69 per share. | 06 Feb 2024 | 26 | 300 (0%) | 0% | 223.7 | 5,816 | Common Stock |
| B. Summy Amy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 73 | 3,951 (0%) | 0% | 223.7 | 16,331 | Common Stock |
| Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 8,534 (0%) | 0% | - | Common Stock | |
| Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 13,380 | 101,491 | - | - | Restricted Stock Unit | |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 236 | 43,453 (0%) | 0% | 223.7 | 52,796 | Common Stock |
| Summy B. Amy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 224 | 4,024 (0%) | 0% | - | Common Stock | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.70 per share. | 06 Feb 2024 | 44 | 7,619 (0%) | 0% | 223.7 | 9,843 | Common Stock |
| Summy Amy B. | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 670 | 7,520 | - | - | Restricted Stock Unit | |
| Wilkinson J. Peter | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 134 | 2,307 (0%) | 0% | - | Common Stock | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 163 | 16,093 | - | - | Restricted Stock Unit | |
| Berberian Lance V. | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 353 | 10,121 | - | - | Restricted Stock Unit | |
| V. Berberian Lance | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 94 | 23,379 (0%) | 0% | 223.7 | 21,029 | Common Stock |
| Schroeder Mark | EVP, Pres Diagnostics & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 6,900 | 6,900 | - | - | Non-qualified Stock Options | |
| Belingard Jean-Luc | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 17,876 (0%) | 0% | - | Common Stock | |
| J. Peter Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 134 | 3,993 | - | - | Restricted Stock Unit | |
| Sandra van der Vaart D. | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 1,160 | 9,025 | - | - | Restricted Stock Unit | |
| Wengel Kathryn E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 944 | 1,891 | - | - | Restricted Stock Unit | |
| Belingard Jean-Luc | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 236 | 1,183 | - | - | Restricted Stock Unit | |
| D. Sandra van der Vaart | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 3,600 | 3,600 | - | - | Non-qualified Stock Options | |
| Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 944 | - | - | Restricted Stock Unit | |
| van der Vaart D. Sandra | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 353 | 8,672 | - | - | Restricted Stock Unit | |
| M. Neupert Peter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 11,943 (0%) | 0% | - | Common Stock | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 138 | 7,500 (0%) | 0% | 223.7 | 30,872 | Common Stock |
| E. Wengel Kathryn | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 944 | - | - | Restricted Stock Unit | |
| Amy Summy B. | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 2,100 | 2,100 | - | - | Non-qualified Stock Options | |
| Anderson Kerrii B. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 944 | 1,891 | - | - | Restricted Stock Unit | |
| Megan Bailey D. | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 1,700 | 1,700 | - | - | Non-qualified Stock Options | |
| J. Caveney Brian | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 517 | 15,880 | - | - | Restricted Stock Unit | |
| D. Megan Bailey | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 67 | 326 (0%) | 0% | - | Common Stock | |
| Williams Robert Sanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 236 | 1,183 | - | - | Restricted Stock Unit | |
| Gary D. Gilliland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 944 | 1,891 | - | - | Restricted Stock Unit | |
| Lance Berberian V. | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 1,070 | 10,474 | - | - | Restricted Stock Unit | |
| Caveney J. Brian | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.70 per share. | 06 Feb 2024 | 33 | 21,051 (0%) | 0% | 223.7 | 7,382 | Common Stock |
| Gary D. Gilliland | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 8,712 (0%) | 0% | - | Common Stock | |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 885 | 36,546 | - | - | Restricted Stock Unit | |
| Schroeder Mark | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 517 | 7,638 (0%) | 0% | - | Common Stock | |
| Kliphouse Marie Kirsten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 944 | 1,891 | - | - | Restricted Stock Unit | |
| Eisenberg A. Glenn | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 2,900 | 37,431 | - | - | Restricted Stock Unit | |
| J. Brian Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 517 | 21,143 (0%) | 0% | - | Common Stock | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 163 | 7,663 (0%) | 0% | - | Common Stock | |
| Brian Caveney J. | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 171 | 20,972 (0%) | 0% | 223.7 | 38,254 | Common Stock |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 400 | 4,127 | - | - | Restricted Stock Unit | |
| H. Schechter Adam | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 1,149 | 51,261 (0%) | 0% | 223.7 | 257,043 | Common Stock |
| Lance Berberian V. | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 3,300 | 3,300 | - | - | Non-qualified Stock Options | |
| Garheng Kong | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 11,898 (0%) | 0% | - | Common Stock | |
| J. Brian Caveney | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 6,200 | 6,200 | - | - | Non-qualified Stock Options | |
| P. Richelle Parham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 944 | 1,891 | - | - | Restricted Stock Unit | |
| Williams Sanders Robert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 8,120 (0%) | 0% | - | Common Stock | |
| Glenn Eisenberg A. | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 9,000 | 9,000 | - | - | Non-qualified Stock Options | |
| Kerrii Anderson B. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 16,222 (0%) | 0% | - | Common Stock | |
| Bailey D. Megan | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 87 | 259 (0%) | 0% | 223.7 | 19,463 | Common Stock |
| Peter Wilkinson J. | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.72 per share. | 06 Feb 2024 | 46 | 2,261 (0%) | 0% | 223.7 | 10,291 | Common Stock |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 944 | 1,891 | - | - | Restricted Stock Unit | |
| Jean-Luc Belingard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 236 | - | - | Restricted Stock Unit | |
| D. Bailey Megan | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 67 | 5,612 | - | - | Restricted Stock Unit | |
| Belingard Jean-Luc | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 95 | 17,781 (0%) | 0% | 223.7 | 21,252 | Common Stock |
| Summy B. Amy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 224 | 7,296 | - | - | Restricted Stock Unit | |
| Bailey Megan D. | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 224 | 5,679 | - | - | Restricted Stock Unit | |
| Parham P. Richelle | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 944 | - | - | Restricted Stock Unit | |
| Megan D. Bailey | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 224 | 346 (0%) | 0% | - | Common Stock | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 353 | 7,989 (0%) | 0% | - | Common Stock | |
| Megan Bailey D. | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 540 | 5,903 | - | - | Restricted Stock Unit | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 1,200 | 1,200 | - | - | Non-qualified Stock Options | |
| Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 41,400 | 41,400 | - | - | Non-qualified Stock Options | |
| Williams Sanders Robert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 236 | - | - | Restricted Stock Unit | |
| Schechter H. Adam | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,250 | 52,410 (0%) | 0% | - | Common Stock | |
| Davis A. Jeffrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 3,619 (0%) | 0% | - | Common Stock | |
| Caveney Brian J. | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 112 | 15,768 | - | - | Restricted Stock Unit | |
| Sandra van der Vaart D. | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 94 | 7,895 (0%) | 0% | 223.7 | 21,029 | Common Stock |
| D. Gilliland Gary | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 944 | - | - | Restricted Stock Unit | |
| Anderson Kerrii B. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 944 | - | - | Restricted Stock Unit | |
| H. Adam Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,250 | 98,241 | - | - | Restricted Stock Unit | |
| Kong Garheng | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 944 | - | - | Restricted Stock Unit | |
| Schroeder Mark | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 517 | 16,256 | - | - | Restricted Stock Unit | |
| M. Peter Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 944 | - | - | Restricted Stock Unit | |
| Caveney J. Brian | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 112 | 21,084 (0%) | 0% | - | Common Stock | |
| Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 944 | 1,891 | - | - | Restricted Stock Unit | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 2,230 | 16,773 | - | - | Restricted Stock Unit | |
| E. Kathryn Wengel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 2,292 (0%) | 0% | - | Common Stock | |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 980 | 5,540 | - | - | Restricted Stock Unit | |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 224 | 5,316 | - | - | Restricted Stock Unit | |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 138 | 5,178 | - | - | Restricted Stock Unit | |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 224 | 3,739 (0%) | 0% | - | Common Stock | |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 78 | 3,661 (0%) | 0% | 223.7 | 17,449 | Common Stock |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 138 | 3,799 (0%) | 0% | - | Common Stock | |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 41 | 3,758 (0%) | 0% | 223.7 | 9,172 | Common Stock |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 3,000 | 3,000 | - | - | Non-qualified Stock Options | |
| Anita Z. Graham | EVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 980 | 2,085 | - | - | Restricted Stock Unit | |
| Anita Z. Graham | EVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 107 | 292 (0%) | 0% | 223.7 | 23,937 | Common Stock |
| Anita Z. Graham | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 369 | 399 (0%) | 0% | - | Common Stock | |
| Anita Z. Graham | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 369 | 1,716 | - | - | Restricted Stock Unit | |
| Anita Z. Graham | EVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 3,000 | 3,000 | - | - | Non-qualified Stock Options | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 264 | 7,900 (0%) | 0% | - | Common Stock | |
| Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 80 | 3,800 (0%) | 0% | 221.5 | 17,723 | Common Stock |
| van der Vaart D. Sandra | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 264 | 7,865 | - | - | Restricted Stock Unit | |
| Amy Summy B. | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 246 | 6,850 | - | - | Restricted Stock Unit | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 495 | 14,543 | - | - | Restricted Stock Unit | |
| J. Caveney Brian | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 495 | 14,387 | - | - | Restricted Stock Unit | |
| Berberian V. Lance | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 331 | 23,209 (0%) | 0% | - | Common Stock | |
| A. Glenn Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 856 | 34,531 | - | - | Restricted Stock Unit | |
| Eisenberg A. Glenn | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 856 | 43,032 (0%) | 0% | - | Common Stock | |
| H. Adam Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 822 | 49,160 (0%) | 0% | 221.5 | 182,106 | Common Stock |
| Schroeder Mark | EVP, Pres Diagnostics & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 132 | 7,121 (0%) | 0% | 221.5 | 29,243 | Common Stock |
| Schroeder Mark | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 495 | 7,253 (0%) | 0% | - | Common Stock | |
| Wilkinson Peter J. | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 131 | 3,727 | - | - | Restricted Stock Unit | |
| van der Vaart Sandra D. | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 71 | 7,829 (0%) | 0% | 221.5 | 15,729 | Common Stock |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.53 per share. | 02 Feb 2024 | 45 | 2,173 (0%) | 0% | 221.5 | 9,969 | Common Stock |
| Adam Schechter H. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 3,094 | 88,111 | - | - | Restricted Stock Unit | |
| Brian Caveney J. | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 495 | 20,792 (0%) | 0% | - | Common Stock | |
| Glenn Eisenberg A. | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 228 | 42,804 (0%) | 0% | 221.5 | 50,511 | Common Stock |
| Schechter H. Adam | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 3,094 | 49,982 (0%) | 0% | - | Common Stock | |
| Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 331 | 9,404 | - | - | Restricted Stock Unit | |
| Sandra van der Vaart D. | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 220.57 per share. | 02 Feb 2024 | 193 | 7,636 (0%) | 0% | 220.6 | 42,570 | Common Stock |
| Summy B. Amy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 246 | 3,880 (0%) | 0% | - | Common Stock | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 131 | 2,218 (0%) | 0% | - | Common Stock | |
| J. Brian Caveney | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 166 | 20,626 (0%) | 0% | 221.5 | 36,776 | Common Stock |
| V. Lance Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 89 | 23,120 (0%) | 0% | 221.5 | 19,717 | Common Stock |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 246 | 3,600 (0%) | 0% | - | Common Stock | |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 85 | 3,515 (0%) | 0% | 221.5 | 18,831 | Common Stock |
| Jonathan P. DiVincenzo | EVP, Pres, Central Labs & Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 246 | 4,560 | - | - | Restricted Stock Unit | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 210.71 per share. | 16 Nov 2023 | 1,384 | 2,087 (0%) | 0% | 210.7 | 291,627 | Common Stock |
| Kirsten Marie Kliphouse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2023 | 372 | 947 | - | - | Restricted Stock Unit | |
| Kirsten Marie Kliphouse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2023 | 372 | 372 (0%) | 0% | - | Common Stock | |
| Kerrii B. Anderson | Director | Sale of securities on an exchange or to another person at price $ 211.57 per share. | 08 Aug 2023 | 5,000 | 15,275 (0%) | 0% | 211.6 | 1,057,833 | Common Stock |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 56 | 3,488 (0%) | 0% | - | Common Stock | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 56 | 3,858 | - | - | Restricted Stock Unit | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 213.59 per share. | 01 Aug 2023 | 17 | 3,471 (0%) | 0% | 213.6 | 3,631 | Common Stock |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 20,193 | 33,957 | - | - | Restricted Stock Unit | |
| Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 73,013 | 89,841 | - | - | Restricted Stock Unit | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 3,104 | 3,851 | - | - | Restricted Stock Unit | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 6,207 | 7,974 | - | - | Restricted Stock Unit | |
| Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 7,758 | 9,585 | - | - | Restricted Stock Unit | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 11,648 | 14,629 | - | - | Restricted Stock Unit | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 11,648 | 14,769 | - | - | Restricted Stock Unit | |
| Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 5,824 | 7,004 | - | - | Restricted Stock Unit | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 240.00 per share. | 29 Jun 2023 | 212 | 7,604 (0%) | 0% | 240 | 50,880 | Common Stock |
| Paul B. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 642 | 642 | - | - | Restricted Stock Unit | |
| Paul Kirchgraber | CEO, Covance Drug Development | Sale of securities on an exchange or to another person at price $ 216.91 per share. | 19 May 2023 | 4,300 | 12,946 (0%) | 0% | 216.9 | 932,707 | Common Stock |
| Paul Kirchgraber | CEO, Covance Drug Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2023 | 4,300 | 0 | - | - | Non-qualified Stock Options | |
| Paul Kirchgraber | CEO, Covance Drug Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 182.51 per share. | 19 May 2023 | 4,300 | 17,246 (0%) | 0% | 182.5 | 784,793 | Common Stock |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Sale of securities on an exchange or to another person at price $ 216.77 per share. | 18 May 2023 | 1,500 | 6,687 (0%) | 0% | 216.8 | 325,155 | Common Stock |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 1,500 | 1,900 | - | - | Non-qualified Stock Options | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 130.60 per share. | 18 May 2023 | 1,500 | 8,187 (0%) | 0% | 130.6 | 195,900 | Common Stock |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 300 | 2,981 | - | - | Restricted Stock Unit | |
| Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 1,000 | 1,000 | - | - | Non-qualified Stock Options | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 440 | 3,121 | - | - | Restricted Stock Unit | |
| Mark Schroeder | EVP, Pres Diagnostics & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 1,400 | 1,400 | - | - | Non-qualified Stock Options | |
| Megan D. Bailey | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 180 | 4,807 | - | - | Restricted Stock Unit | |
| Megan D. Bailey | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 600 | 600 | - | - | Non-qualified Stock Options | |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 5,179 | 42,176 (0%) | 0% | 224.7 | 1,163,721 | Common Stock |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 11,715 | 47,355 (0%) | 0% | 0 | Common Stock | |
| Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 42,353 | 65,534 (0%) | 0% | 0 | Common Stock | |
| Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 18,646 | 46,888 (0%) | 0% | 224.7 | 4,189,756 | Common Stock |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 1,798 | 3,958 (0%) | 0% | 0 | Common Stock | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 526 | 3,432 (0%) | 0% | 224.7 | 118,192 | Common Stock |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 1,371 | 7,790 (0%) | 0% | 224.7 | 308,064 | Common Stock |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 3,609 | 9,161 (0%) | 0% | 0 | Common Stock | |
| Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 1,799 | 22,878 (0%) | 0% | 224.7 | 404,235 | Common Stock |
| Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 4,509 | 24,677 (0%) | 0% | 0 | Common Stock | |
| Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 2,990 | 20,185 (0%) | 0% | 224.7 | 671,853 | Common Stock |
| Brian J. Caveney | EVP, President of Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 6,763 | 23,175 (0%) | 0% | 0 | Common Stock | |
| Paul Kirchgraber | CEO, Covance Drug Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 2,886 | 12,946 (0%) | 0% | 224.7 | 648,484 | Common Stock |
| Paul Kirchgraber | CEO, Covance Drug Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 6,763 | 15,832 (0%) | 0% | 0 | Common Stock | |
| Judith C. Seltz | EVP, CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 3,381 | 5,345 (0%) | 0% | 0 | Common Stock | |
| Judith C. Seltz | EVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 1,164 | 4,181 (0%) | 0% | 224.7 | 261,551 | Common Stock |
| Mark Schroeder | EVP, President-Diagnostics Lab | Sale of securities on an exchange or to another person at price $ 225.81 per share. | 30 Mar 2023 | 3,897 | 6,687 (0%) | 0% | 225.8 | 879,982 | Common Stock |
| Mark Schroeder | EVP, President-Diagnostics Lab | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 6,763 | 13,450 (0%) | 0% | 0 | Common Stock | |
| Mark Schroeder | EVP, President-Diagnostics Lab | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 2,866 | 10,584 (0%) | 0% | 224.7 | 643,990 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 3,234 | 4,903 (0%) | 0% | 0 | Common Stock | |
| Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 1,269 | 3,634 (0%) | 0% | 224.7 | 285,144 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.46 per share. | 02 Mar 2023 | 374 | 1,669 (0%) | 0% | 239.5 | 89,558 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,340 | 1,180 | - | - | Restricted Stock Unit | |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,340 | 2,043 (0%) | 0% | - | Common Stock | |
| Paul Kirchgraber | CEO, Covance Drug Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 182.51 per share. | 21 Feb 2023 | 3,000 | 17,069 (0%) | 0% | 182.5 | 547,530 | Common Stock |
| Paul Kirchgraber | CEO, Covance Drug Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 3,000 | 4,300 | - | - | Non-qualified Stock Options | |
| Paul Kirchgraber | CEO, Covance Drug Development | Sale of securities on an exchange or to another person at price $ 250.58 per share. | 21 Feb 2023 | 8,000 | 9,069 (0%) | 0% | 250.6 | 2,004,675 | Common Stock |
| Mark Schroeder | EVP, President-Diagnostics Lab | Sale of securities on an exchange or to another person at price $ 247.63 per share. | 14 Feb 2023 | 309 | 6,687 (0%) | 0% | 247.6 | 76,518 | Common Stock |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 723 | 35,835 (0%) | 0% | - | Common Stock | |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 723 | 13,764 | - | - | Restricted Stock Unit | |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 195 | 35,640 (0%) | 0% | 248.1 | 48,385 | Common Stock |
| Jean-Luc Belingard | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 75 | 16,929 (0%) | 0% | 248.1 | 18,610 | Common Stock |
| Jean-Luc Belingard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 17,004 (0%) | 0% | - | Common Stock | |
| Jean-Luc Belingard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 849 | - | - | Restricted Stock Unit | |
| Kerrii B. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 20,275 (0%) | 0% | - | Common Stock | |
| Kerrii B. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 849 | - | - | Restricted Stock Unit | |
| Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 10,996 (0%) | 0% | - | Common Stock | |
| Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 849 | - | - | Restricted Stock Unit | |
| Robert Sanders Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 7,173 (0%) | 0% | - | Common Stock | |
| Robert Sanders Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 849 | - | - | Restricted Stock Unit | |
| Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,656 | 24,351 (0%) | 0% | - | Common Stock | |
| Adam H. Schechter | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 1,170 | 23,181 (0%) | 0% | 248.1 | 290,312 | Common Stock |
| Adam H. Schechter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,656 | 16,828 | - | - | Restricted Stock Unit | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 38 | 2,160 (0%) | 0% | 248.1 | 9,429 | Common Stock |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 110 | 747 | - | - | Restricted Stock Unit | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 110 | 2,198 (0%) | 0% | - | Common Stock | |
| Garheng Kong | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 849 | - | - | Restricted Stock Unit | |
| Garheng Kong | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 10,951 (0%) | 0% | - | Common Stock | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 290 | 1,767 | - | - | Restricted Stock Unit | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 290 | 5,630 (0%) | 0% | - | Common Stock | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 78 | 5,552 (0%) | 0% | 248.1 | 19,354 | Common Stock |
| Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 849 | - | - | Restricted Stock Unit | |
| Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 7,587 (0%) | 0% | - | Common Stock | |
| D. Gary Gilliland | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 7,765 (0%) | 0% | - | Common Stock | |
| D. Gary Gilliland | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 849 | - | - | Restricted Stock Unit | |
| Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 85 | 20,168 (0%) | 0% | 248.1 | 21,091 | Common Stock |
| Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 290 | 1,827 | - | - | Restricted Stock Unit | |
| Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 290 | 20,253 (0%) | 0% | - | Common Stock | |
| Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 849 | - | - | Restricted Stock Unit | |
| Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 2,672 (0%) | 0% | - | Common Stock | |
| Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 423 | 2,681 | - | - | Restricted Stock Unit | |
| Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 423 | 16,536 (0%) | 0% | - | Common Stock | |
| Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 124 | 16,412 (0%) | 0% | 248.1 | 30,768 | Common Stock |
| Kathryn E. Wengel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 1,345 (0%) | 0% | - | Common Stock | |
| Kathryn E. Wengel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 849 | - | - | Restricted Stock Unit | |
| Paul Kirchgraber | CEO, Covance Drug Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 483 | 3,001 | - | - | Restricted Stock Unit | |
| Paul Kirchgraber | CEO, Covance Drug Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 483 | 14,211 (0%) | 0% | - | Common Stock | |
| Paul Kirchgraber | CEO, Covance Drug Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 142 | 14,069 (0%) | 0% | 248.1 | 35,234 | Common Stock |
| Judith C. Seltz | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 236 | 1,464 | - | - | Restricted Stock Unit | |
| Judith C. Seltz | EVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 236 | 2,033 (0%) | 0% | - | Common Stock | |
| Judith C. Seltz | EVP, CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 69 | 1,964 (0%) | 0% | 248.1 | 17,121 | Common Stock |
| Mark Schroeder | EVP, President-Diagnostics Lab | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 114 | 6,996 (0%) | 0% | 248.1 | 28,287 | Common Stock |
| Mark Schroeder | EVP, President-Diagnostics Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 423 | 7,110 (0%) | 0% | - | Common Stock | |
| Mark Schroeder | EVP, President-Diagnostics Lab | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 423 | 2,681 | - | - | Restricted Stock Unit | |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 180 | 757 (0%) | 0% | - | Common Stock | |
| Amy B. Summy | EVP, Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 54 | 703 (0%) | 0% | 248.1 | 13,399 | Common Stock |
| Amy B. Summy | EVP, Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 180 | 2,520 | - | - | Restricted Stock Unit | |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 2,380 | 14,487 | - | - | Restricted Stock Unit | |
| Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 7,500 | 7,500 | - | - | Non-qualified Stock Options | |
| Jean-Luc Belingard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 849 | 1,591 | - | - | Restricted Stock Unit | |
| Kerrii B. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 849 | 1,591 | - | - | Restricted Stock Unit | |
| Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 849 | 1,591 | - | - | Restricted Stock Unit | |
| Robert Sanders Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 849 | 1,591 | - | - | Restricted Stock Unit | |
| Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 8,740 | 19,484 | - | - | Restricted Stock Unit | |
| Adam H. Schechter | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 27,400 | 27,400 | - | - | Non-qualified Stock Options | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 360 | 857 | - | - | Restricted Stock Unit | |
| Peter J. Wilkinson | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 1,100 | 1,100 | - | - | Non-qualified Stock Options | |
| Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 849 | 1,591 | - | - | Restricted Stock Unit | |
| Sandra D. van der Vaart | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 243.01 per share. | 07 Feb 2023 | 219 | 5,340 (0%) | 0% | 243.0 | 53,219 | Common Stock |